The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database

被引:68
作者
Navarro, V
Herrine, S
Katopes, C
Colombe, B
Spain, CV
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med Gastroenterol & Hepatol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ Hosp, Dept Tissue Typing, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Jefferson Coll Grad Studies, Philadelphia, PA 19107 USA
关键词
D O I
10.1002/lt.20680
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this study was to explore the relationship between human leukocyte antigen (HLA) compatibility and liver transplantation outcomes by analyzing the effect of HLA compatibility on 5-year graft survival. We analyzed first liver transplants between 1987 and 2002 in the Organ Procurement and Transplantation Network (OPTN) database, where A, B, or DR loci data were available. Graft failure was defined as retransplantation or death from transplant-related cause. We evaluated associations between total and locus-specific match levels and 5-year graft survival. Multivariable Cox proportional-hazard models were used to evaluate statistical interactions and adjust for the effect of potential confounders. Among 29,675 first-time transplants, the overall degree of HLA match had no effect on 5-year graft survival, even after controlling for potential confounders. Univariate and multivariable analyses showed that the 0 HLA antigen mismatch cohort of patients had higher 5-year graft failure rates than the other 6 antigen mismatch groups. However, this occurred in a small group with a disproportionately large number of live donors and split-liver recipients. When these recipients were excluded from the analysis, the effect was no longer seen. Finally, multivariable, locus-specific analyses showed no association between 5-year graft survival and degree of match/mismatch and the A, B, or DR loci. In conclusion, this careful examination of the OPTN database, with respect to HLA match or mismatch and liver graft survival, reaffirms that HLA matching has no clinically significant impact on this outcome.
引用
收藏
页码:652 / 658
页数:7
相关论文
共 16 条
[1]  
Allison PD, 1995, SURVIVAL ANAL USING, P111
[2]  
CALMUS Y, 1989, J HEPATOL, V9, P16
[3]   Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation [J].
Charco, R ;
Vargas, V ;
Balsells, J ;
Lazaro, JL ;
Murio, E ;
Jaurrieta, E ;
Martorell, J ;
Margarit, C .
JOURNAL OF HEPATOLOGY, 1996, 24 (04) :452-459
[4]   Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for monitoring patients [J].
Creput, C ;
Le Friec, G ;
Bahri, R ;
Amiot, L ;
Charpentier, B ;
Carosella, E ;
Rouas-Freiss, N ;
Durrbach, A .
HUMAN IMMUNOLOGY, 2003, 64 (11) :1033-1038
[5]   Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation [J].
Créput, C ;
Durrbach, A ;
Menier, C ;
Guettier, C ;
Samuel, D ;
Dausset, J ;
Charpentier, B ;
Carosella, ED ;
Rouas-Freiss, N .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :587-594
[6]  
DONALDSON P, 1993, HEPATOLOGY, V17, P1008, DOI 10.1002/hep.1840170611
[7]  
GAUR LK, 1994, HUM IMMUNOL, V40, P7
[8]  
Hosmer D., 1999, WILEY PS TX
[9]  
KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P448
[10]  
KNECHTLE SJ, 1993, SURGERY, V114, P667